VIVA 17 Round-up: Medtronic touts real-world data for In.Pact Admiral drug-coated balloon

Medtronic (NYSE:MDT) touted data for its In.Pact Admiral drug-coated balloon this week at the Vascular Interventional Advances (VIVA) 2017 conference.

The company presented two-year, real-world data from the In.Pact Global study, as well as four-year results from the pivotal In.Pact SFA study.

Get the full story at our sister site, Drug Delivery Business News.

The post VIVA 17 Round-up: Medtronic touts real-world data for In.Pact Admiral drug-coated balloon appeared first on MassDevice.

from MassDevice http://ift.tt/2vSxOE0